FEDERATED HERMES, INC.

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in PLRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$33,122

-$45,818 QoQ

Shares Held

29,055

-53.6% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 86 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. PLRX ranks #112 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$33,122	29,055	-53.6%	Shares	Defined	2026-08-12
2026-03-31	$78,940	62,651	+5.3%	Shares	Defined	2026-05-11
2025-12-31	$72,583	59,495	+7.6%	Shares	Defined	2026-02-12
2025-09-30	$81,838	55,296	-35.3%	Shares	Defined	2025-11-03
2025-06-30	$99,088	85,421	+44.3%	Shares	Defined	2025-08-13
2025-03-31	$79,932	59,209	+1557.6%	Shares	Defined	2025-05-08
2024-12-31	$47,043	3,572	+61.7%	Shares	Defined	2025-02-13
2024-09-30	$24,762	2,209	-97.2%	Shares	Defined	2024-11-13
2023-03-31	$2,120,871	79,732	0.0%	Shares	Defined	2023-05-08
2022-12-31	$1,541,219	79,732	0.0%	Shares	Defined	2023-02-13
2022-09-30	$1,665,601	79,732	-75.9%	Shares	Defined	2022-11-14
2022-06-30	$2,655,274	331,495	+25.0%	Shares	Defined	2022-09-16
2022-03-31	$1,858,855	265,172	+624.2%	Shares	Defined	2022-05-13
2021-12-31	$494,343	36,618	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.